aviv

Radware Schedules Conference Call for Its Second Quarter 2025 Earnings

TEL AVIV, Israel, July 02, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a global leader in application security and delivery…

2 days ago

LightSolver and HLRS Present Joint Research on Optical Computingat ISC High Performance 2025

TEL AVIV, Israel, June 10, 2025 (GLOBE NEWSWIRE) -- LightSolver, inventors of a new laser-based computing paradigm, and HLRS (High-Performance…

3 weeks ago

Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study

TEL AVIV, Israel, June 9, 2025 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, is happy to announce the…

3 weeks ago

ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)

June 05, 2025 16:31 ET  | Source: ImPact Biotech –  Previously inoperable patient converted to eligible for resection, underwent pancreaticoduodenectomy,…

4 weeks ago

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of…

1 month ago

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TE

Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED)…

1 month ago